Blocid 500 mg+100 mg (Chewable Tablet)

Title

• Blocid Tablets

Categories

• Medicine
• Gastroesophageal Reflux Treatment
• Antacid
• Pharmacology

Description

• Blocid Tablets are indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus, such as acid regurgitation, heartburn, and indigestion.

Usage instructions

• Adults and children over 12 years: 1-2 tablets 3-4 times daily, after meals and before bedtime.
• Children 6-12 years: ½-1 tablet 3-4 times daily, after meals and before bedtime.

Dosage form

• Tablet
• Suspension

Dosage recommendations

• Use in children: Not recommended under 2 years of age.
• Elderly: No dose modifications required.
• Renal Insufficiency: Caution if a highly restricted salt diet is necessary.

Interaction warning

• A time interval of 2 hours should be considered between this intake and the administration of other medicinal products, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine.

Contraindications

• Contraindicated in patients with known hypersensitivity to Sodium Alginate and Potassium Bicarbonate.

Side effects

• Nausea
• Constipation
• Diarrhea
• Headache
• Sensation of swelling (in case of overdose)

Pregnancy lactation info

• Can be used during pregnancy if clinically needed.
• No known effect on breast-fed infants.
• Can be used during breastfeeding.

Precautions warnings

• Prescribed with caution in patients with renal impairment and congestive cardiac failure.
• Care should be taken in treating patients with hypercalcemia, nephrocalcinosis, and recurrent calcium-containing renal calculi.

Overdose effects

• Overdosage is a rare case. In case of overdose, consult with a registered physician.

Therapeutic class

• Antacids

Storage conditions

• Keep below 30°C temperature, away from light & moisture.
• Keep out of the reach of children.

Pharmacology

• The combination of Sodium Alginate and Potassium Bicarbonate forms a gel in the stomach, preventing acid reflux into the esophagus, and lasts for up to 4 hours.

Indications

• Relief from symptoms of gastroesophageal reflux during concomitant treatment with or following the withdrawal of acid suppressing therapy.

Age recommendations

• Recommended for adults and children over 6 years.

Administration timing

• After meals and before bedtime

Child dosage recommendations

• Children 2-12 years: 2.5-5ml (½-1 teaspoonful) 3-4 times daily

Hepatic impairment

• No dose modifications are necessary.

Renal impairment

• Prescribed with caution in patients with renal impairment.

Gastric acid levels

• Possibility of reduced efficacy in patients with very low levels of gastric acid.

Effectiveness evaluation

• If symptoms do not improve after seven days, review the clinical situation.

Usage age limit

• Not recommended for children under 2 years of age.

Salt diet caution

• Caution if a highly restricted salt diet is necessary.

Hypercalcemia patients

• Care needs to be taken in treating patients with hypercalcemia.

Nephrocalcinosis patients

• Care needs to be taken in treating patients with nephrocalcinosis.

Calcium-containing renal calculi patients

• Care needs to be taken in treating patients with recurrent calcium-containing renal calculi.

Acid reflux symptoms

• Relief from symptoms of laryngopharyngeal reflux, hoarseness, voice disorders, sore throats, and cough.

Acid suppressing therapy withdrawal

• Used for the treatment of symptoms during concomitant treatment with or following the withdrawal of acid suppressing therapy.

Allergen hypersensitivity

• Contraindicated in patients with known hypersensitivity to Sodium Alginate and Potassium Bicarbonate.

Nonsystemic action

• The mode of action is physical and does not depend on absorption into the systemic circulation.

Raft duration

• The raft formed by the combination lasts for up to 4 hours on top of the stomach contents.

Digestive system breakdown

• The raft formed in the stomach is broken down in the digestive system and excreted in the feces.

Rare overdose case

• Overdosage with this formulation is a rare case.

Pregnancy clinical need

• Can be used during pregnancy if clinically needed.

Breastfeeding safe

• No known effect on breast-fed infants.
• Can be used during breastfeeding.

Safe for elderly

• No dose modifications are necessary for the elderly.

Safe for reduced salt diet

• Caution if a highly restricted salt diet is necessary.

Temperature sensitive

• Store below 30°C temperature.

Light mositure sensitive

• Store away from light & moisture.

Child-proof packaging

• Keep out of the reach of children.

Related Brands

• Algicid (500 mg+100 mg)/5 ml (Oral Suspension) - incepta-pharmaceuticals-ltd
• Algisum 500 mg+100 mg (Chewable Tablet) - opsonin-pharma-ltd
• Algisum (500 mg+100 mg)/5 ml (Oral Suspension) - opsonin-pharma-ltd
• Asynta (500 mg+100 mg)/5 ml (Oral Suspension) - square-pharmaceuticals-plc
• Xerocid 500 mg+100 mg (Chewable Tablet) - novelta-bestway-pharma-ltd